Holen Sie sich die Stockscreener-App
3.37
21.66%
0.60
Handel nachbörslich:
3.27
-0.10
-2.97%
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
Intelligent Bio Solutions (NASDAQ:INBS): Can Commercial Adoption Accelerate? - Kalkine Media
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? - Benzinga
Intelligent Bio Solutions receives ISO 13485:2016 recertification - Investing.com
Intelligent Bio Solutions receives ISO 13485:2016 recertification By Investing.com - Investing.com Canada
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - The Manila Times
A Fingerprint Drug Test Aligns With the FDA's New Regulation—What's Next? - Stock Titan
What Should Readers Watch in Intelligent Bio Solutions (NASDAQ:INBS) as Diagnostic Adoption Comes Into Focus? - kalkinemedia.com
Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com - Investing.com Canada
Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study - tipranks.com
Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026 - TradingView
Intelligent Bio Solutions Inc. (INBS) stock price, news, quote and history - Yahoo Finance Singapore
INBS Looks 48.6% Undervalued on GF Value™ but Faces Challenges - GuruFocus
Intelligent Bio Solutions completes FDA clinical study program - Investing.com
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - The Manila Times
Intelligent Bio Solutions Completes Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - marketscreener.com
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions Inc (INBS) Stock News Today - TradingKey
INBS Q4'26 Earnings: revenue estimate is 1.22M USD - TradingView
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System Supporting FDA 510(k) Submission - marketscreener.com
Intelligent Bio Solutions Advances Fingerprint Drug Screening Program - tipranks.com
Intelligent Bio Solutions completes usability study for FDA filing - Investing.com
Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track - TradingView
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission - The Manila Times
15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training - Stock Titan
Intelligent Bio Solutions Expands Share Count Through Equity Transactions - tipranks.com
Intelligent Bio Solutions Advances FDA Path with Interference Study - TipRanks
Intelligent Bio Solutions reports 3,018,188 shares outstanding as of July 31, 2026 - TradingView
Intelligent Bio Solutions Inc. Completes Interference Study for Intelligent Fingerprinting Drug Screening System - marketscreener.com
INBS|Intelligent Bio Solutions Inc|Price:1.810|Chg%:+0.250 - TradingKey
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: EPS Miss Widens as Revenue Remains Undisclosed - dars.gov.et
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Intelligent Bio Solutions Inc (INBS) Balance Sheet - TradingKey
Free cash flow per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Book value per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Revenue per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Institutional Confidence - TradingKey
INBS|Intelligent Bio Solutions Inc|Price:1.750|Chg%:-0.060 - TradingKey
Long term debt to total equity ratio of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Total equity of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Cash flow from financing activities of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Gross profit of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc. Income Statement – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-than-Expected Loss Weighs on SharesAnalyst Earnings Estimate - dars.gov.et
Intelligent Bio Solutions Inc (INBS) Cash Flow - TradingKey
Intelligent Bio Solutions Inc. Revenue Breakdown – NASDAQ:INBS - TradingView
Intelligent Bio Solutions Resolves Cybersecurity Issues, Prepares FDA 510(k) Submission for U.S. Drug Screening Market Expansion – Minichart - Minichart
Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Intelligent Bio Solutions Advances FDA 510(k) Cybersecurity Readiness - TipRanks
Intelligent Bio Solutions addresses cybersecurity issues, keeps 510(k) submission on track for H2 2026 - TradingView
INTELLIGENT BIO SOLUTIONSON TRACK FOR 510(K) SUBMISSION IN H2 2026 - Moomoo
Intelligent Bio Solutions addresses FDA cybersecurity items - Investing.com
Intelligent Bio Solutions Resolves Final Cybersecurity and Software Review Items Ahead of Planned H2 2026 510(k) Submission - Quiver Quantitative
Fingerprint Drug Test Delivers Results in Under 10 Minutes; FDA Filing Planned - Stock Titan
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry - The Manila Times
Intelligent Bio Solutions (INBS) Drops 8% as Stock Approaches Key Support LevelVolume Weighted Price - dars.gov.et
Intelligent Bio Solutions (INBS) Completes Precision Testing for Drug Screening System - GuruFocus
Intelligent Bio Solutions completes precision t... - Pluang
Intelligent Bio Solutions Completes Precision Testing of Intelligent Fingerprinting Drug Screening System - Moomoo
Intelligent Bio Solutions completes precision testing for FDA filing By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Advances Fingerprint Drug Screening Precision - TipRanks
Intelligent Bio Solutions completes 1,600+ precision tests to bolster FDA 510(k) submission - TradingView
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market - The Manila Times
Intelligent Bio Solutions completes precision testing for FDA filing - Investing.com
Intelligent Bio Solutions Completes Precision Testing for FDA 510(k) Submission of Fingerprint Drug Screening System for Codeine Detection - Quiver Quantitative
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):